Hairy Cell Leukemia
Showing 1 - 25 of >10,000
Hairy Cell Leukemia Patients
Not yet recruiting
- Hairy Cell Leukemia
- (no location specified)
May 5, 2023
Hairy Cell Leukemia, Hairy Cell Leukemia Variant Trial run by the NCI (CD22CART cell infusion)
Recruiting
- Hairy Cell Leukemia
- Hairy Cell Leukemia Variant
- CD22CART cell infusion
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Hairy Cell Leukemia Trial run by the NCI (Moxetumomab Pasudotox-tdfk, Rituximab, Ruxience)
Active, not recruiting
- Hairy Cell Leukemia
- Moxetumomab Pasudotox-tdfk
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Hairy Cell Leukemia Trial in La Jolla (Low dose vemurafenib plus rituximab)
Recruiting
- Hairy Cell Leukemia
- Low dose vemurafenib plus rituximab
-
La Jolla, CaliforniaScripps MD Anderson Cancer Center
May 19, 2022
Hairy Cell Leukemia Trial run by the NCI (Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin)
Active, not recruiting
- Hairy Cell Leukemia
- Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 13, 2022
Hairy Cell and Other Leukemias, and to Develop Recombinant
Recruiting
- Hairy Cell Leukemia (HCL)
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Relapsed/Refractory Waldenstrom Macroglobulinemia, Relapsed/Refractory Richter Transformation, Relapsed/Refractory Burkitt
Not yet recruiting
- Relapsed/Refractory Waldenstrom Macroglobulinemia
- +3 more
- Brexucabtagene Autoleucel
- +2 more
- (no location specified)
Sep 8, 2022
Moxetumomab Pasudotox-tdfk (LUMOXITI)
Recruiting
- Hairy Cell Leukemia
-
Pueblo, Colorado
- +1 more
Aug 17, 2022
Hairy Cell Leukemia, Leukemia, Leukemia, Hairy Cell Trial in United States (Vemurafenib, Obinutuzumab)
Active, not recruiting
- Hairy Cell Leukemia
- +2 more
-
New Haven, Connecticut
- +8 more
Feb 7, 2022
Patients Previously Treated WithMustang Bio CAR-T Cell
Enrolling by invitation
- Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- +10 more
- Prior MB-102 CAR-T cell investigational product.
- Prior MB-106 CAR-T cell investigational product.
-
Duarte, California
- +4 more
Dec 8, 2022
Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in
Recruiting
- Recurrent Acute Leukemia
- +16 more
- Acetaminophen
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 22, 2022
Hairy Cell Leukemia Patient Data Registry
Recruiting
- Leukemia, Other
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 1, 2021
Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,
Active, not recruiting
- Adult Grade III Lymphomatoid Granulomatosis
- +23 more
- autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
B-cell Chronic Lymphoid Malignancies Markers
Recruiting
- Chronic Lymphocytic Leukemia
- +5 more
-
Strasbourg, FranceHematology Laboratory - Strasbourg University Hospitals
Jul 2, 2021
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia
- +125 more
- tetanus-CMV fusion peptide vaccine
- laboratory biomarker analysis
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Relapsed/Refractory Hairy Cell Leukemia Trial (Moxetumomab Pasudotox)
Approved for marketing
- Relapsed/Refractory Hairy Cell Leukemia
- Moxetumomab Pasudotox
- (no location specified)
Jun 26, 2020
Anemia, B-Cell Prolymphocytic Leukemia, Grade 1 Follicular Lymphoma Trial in Portland (drug, other, biological)
Completed
- Anemia
- +13 more
- Entospletinib
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Apr 29, 2021
Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Diffuse Large Cell
Active, not recruiting
- Adult Grade III Lymphomatoid Granulomatosis
- +71 more
- lenalidomide
- +8 more
-
Chicago, Illinois
- +5 more
Oct 8, 2021
Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma
Terminated
- Adult Grade III Lymphomatoid Granulomatosis
- +116 more
- brentuximab vedotin
- +2 more
-
Chicago, Illinois
- +2 more
Aug 30, 2021
Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Burkitt Lymphoma
Completed
- Adult Grade III Lymphomatoid Granulomatosis
- +88 more
- bortezomib
- +2 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Apr 14, 2021
Hairy Cell Leukemia, Recurrent Hairy Cell Leukemia Trial in Houston (drug, other, biological)
Recruiting
- Hairy Cell Leukemia
- Recurrent Hairy Cell Leukemia
- Cladribine
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Mar 20, 2020
Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +46 more
- Fludarabine
- +8 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 10, 2021